Cardiac Rhythm Management Devices | Global | 2014 | Market Analysis
The mature global CRM device market will expand until 2019, primarily driven by favorable demographics and the launch of premium-priced novel devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs. By 2022, the market will undergo a slight decline as price erosion takes place across all segments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the global cardiac rhythm management device market across a 10-year period.